医学
肝移植
背景(考古学)
内科学
肝癌
存活率
移植
胃肠病学
结直肠癌
肿瘤科
癌症
外科
生物
古生物学
作者
Pål‐Dag Line,Svein Dueland
标识
DOI:10.1016/j.jhep.2020.08.015
摘要
Assessing the balance between survival and recurrence after transplantation for secondary liver tumours should be based on the type of cancer in question. For neuroendocrine liver metastases, high recurrence rates are clearly related to reduced long-term survival. For colorectal liver metastases, experience to date indicates that pulmonary recurrence alone has a modest impact on survival outcomes. Further studies focusing on this group of patients will be important for the development of this field of transplant oncology. Liver transplantation for secondary liver tumours should be implemented in accordance with stringent transplant criteria and preferably in the context of prospective trials. Expansion of the donor pool by utilising extended criteria donors and partial liver transplantation could be considered for this indication.
科研通智能强力驱动
Strongly Powered by AbleSci AI